Working… Menu

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02638428
Recruitment Status : Recruiting
First Posted : December 23, 2015
Last Update Posted : March 19, 2020
Ministry of Health, Republic of Korea
Information provided by (Responsible Party):
Samsung Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2023